MedTrace Logo

Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria

NCT07484971 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2026-04-17

No results posted yet for this study

Summary

The goal of this observational study is to describe the demographic, epidemiological, clinical, and outcome characteristics of patients with prostate cancer.

It also aims to analyze the diagnostic approaches and management strategies used in the care of these patients in Algeria.

Conditions

  • Prostate Cancer
  • Prostate Cancer (Diagnosis)
  • Prostate Cancer (Post Prostatectomy)
  • Prostate Cancer Patients Treated by Radiotherapy
  • Prostate Cancer Metastatic
  • Prostate Cancer (Adenocarcinoma)

Sponsors & Collaborators

  • ES Clinical Research

    collaborator UNKNOWN

  • Ipsen

    collaborator INDUSTRY

  • Astellas Pharma Inc

    collaborator INDUSTRY

  • Société Algérienne de Formation et Recherche en Oncologie

    lead OTHER

Eligibility

Min Age
19 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-21
Primary Completion
2026-07-21
Completion
2026-07-21

Countries

  • Algeria

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07484971 on ClinicalTrials.gov